Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans.
Level 5 - mechanism / opinion, no new human data
Preclinical animal models and human experimental challenge measuring a surrogate endpoint
PubMed 25804610 · doi:10.1158/1940-6207.CAPR-14-0362
What was done
Researchers evaluated the protective effects of Nrf2 activation against solar-simulated ultraviolet (UV) radiation in both mouse models and human volunteers. In SKH-1 hairless mice, investigators compared solar-simulated UV-induced skin tumor formation between mice with genetically constitutively activated Nrf2 and wild-type controls. They also tested topical application of the Nrf2 activator TBE-31 (40 nmol biweekly) in mice receiving chronic azathioprine immunosuppression, and measured acute post-UV skin expression of IL6, IL1β, and COX2 under genetic or pharmacological Nrf2 activation. In healthy human subjects, topical sulforaphane-containing extracts were applied before solar-simulated UV radiation to evaluate skin erythema as a surrogate endpoint.
What was found
No numerical values, percentages, or statistical significance metrics are reported in the abstract. Qualitatively, constitutive Nrf2 activation in mice reduced solar-simulated UV-induced cutaneous tumor incidence, multiplicity, and burden relative to wild-type controls. Topical TBE-31 similarly protected against UV-induced tumors in azathioprine-treated mice. Both genetic and pharmacological Nrf2 activation lowered acute post-UV expression of IL6, IL1β, and COX2 in mice. In healthy humans, topical sulforaphane reduced UV-induced skin erythema.
Why it matters
This study provides mechanistic and preclinical evidence that Nrf2 activation acts as a cytoprotective defense against solar UV radiation and carcinogenesis rather than driving tumor formation, supporting its potential utility in photoprotection.
Limits
The abstract provides no sample sizes for either the animal or human experiments. No quantitative data, effect sizes, or confidence intervals are reported. The human component evaluated only acute skin erythema as a short-term surrogate marker rather than clinical skin cancer prevention outcomes.
Cited by
- supports Topical application of sulforaphane protects human skin against ultraviolet radiation.